Skip to main content

Click "Menu" to toggle open, click "Menu" again to close

Eyal Oren PhD, MS

Eyal  Oren PhD, MS

Assistant Professor

Epidemiology and Biostatistics Department

1295 N. Martin Ave
Campus PO Box: 245211
Drachman Hall A226
Tucson, AZ 85724
(520) 626-7008


Eyal Oren, PhD, MS, is an epidemiologist interested in infectious disease, with an emphasis on respiratory health. He is interested in multidisciplinary, community-engaged approaches to addressing population health disparities and collaborative work that is innovative and emphasizes new tools and technologies. Methodologically, his focus is on the intersection between social, environmental, and spatial epidemiologic methods, and their application to both health differences and disparities.


2010   Ph.D., Epidemiology, University of Washington

2004  M.S., Epidemiology (Certificate in International Health),University  of Washington

1998  B.A., Neurobiology & Behavior (Concentration in Cognitive Science), Cornell University


EPID 671          Social Epidemiology

CPH  479          Principles of Infectious Diseases Epidemiology

EPID 309          Introduction to Epidemiology

Research Interests

Most recently, my work has explored the ties between the environment, social factors and respiratory health. Two of my primary active projects include a study examining the association between stress and asthma among middle-schoolers, as well as the use of health applications for medication adherence for latent tuberculosis infection. My focus has primarily been on vulnerable populations, both in the US, on the border, and globally, in Vietnam, Mexico and Ghana. In my previous life in government, I conducted epidemiologic investigations to support disease control and outbreak management; and evaluated the effectiveness of disease surveillance activities.

Research Group Homepage:


Infectious disease epidemiology
Tuberculosis (both active disease and latent infection)
Respiratory Health
Molecular epidemiology
Epidemiology in public health practice
Surveillance systems
Assessment of new technologies
Social epidemiology and health disparities
Global  and border health
Program evaluation, Monitoring & Evaluation
Climate change and respiratory health outcomes
Clinical trials
Multilevel/Hierarchical Models
Pilot & Feasibility studies
Systematic Reviews and Meta-Analyses

Current Project Areas

Feasibility of latent tuberculosis screening among migrant farmworkers
Adherence to Latent TB Infection among at-risk populations
Perceptions and social indices of walkability in Tucson, AZ
New technologies for latent tuberculosis infection
Climate change and respiratory health
Helicobacter pylori in Arizona
Stress and asthma in public schools
Biosurveillance and multi-drug resistant pathogens
Role of social media in respiratory outcomes

Selected Publications (of 30+ publications)

1. Fiero M, Huang S, Oren E, Bell ML. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review. Trials. 2016; 17 (72). DOI: 10.1186/s13063-016-1201-z
2. Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Oren E et al. Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.  Plos One. 2016. 11(5):e0155968.
3. Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review (In Press, Cancer Epidemiology, Biomarkers and Prevention).
4. Campo M, Shrestha A, Oren E,  Thiede H, Duchin J, Narita M, Crothers K. Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA. Epidemiol Infect, 2013; 25:1-8.
5. Oren E, Narita M, Nolan C, Mayer J. The role of area-level socioeconomic disadvantage on severe pulmonary tuberculosis. Public Health Reports, 2013; 128(2):99-109.
6. Lindquist S, Ghosh-Chatterjee S, Field K, Allen S, Narita M, Oren E. Public Health Prioritization of TB Genotype Clusters. Emerging Infectious Diseases, 2013. 19(3): 493-6.
7. Horne D, Campo M, Arentz M, Oren E, Crothers K, Narita M. Association between Smoking and Latent Tuberculosis in the U.S. Population. PLOS One, 2012;7(11):e49050.
8. Oren E, Koepsell T, Leroux B, Mayer J. Area-based Socioeconomic Disadvantage and Tuberculosis Incidence. International Journal of the Union against TB and Lung Disease, 2012; 16(7):880-5.
9. Barry PM, Shaw T, Oren E, Field K, Funk E, Langer AJ, Gardner TJ. Multistate Outbreak of Multidrug-Resistant Tuberculosis Identified by Genotype Cluster Investigation among Foreign-Born Seafood Production Workers. Emerging Infectious Diseases, 2012; 18(1): 113-116.
10. Oren E, Winston CA, Pratt R, Robison VA, Narita M. Epidemiology of Urban Tuberculosis in the United States, 2000-2007. American Journal of Public Health. 2011; 101:1256-1263.
11. Horne D, Oren E, Spitters CE, Johnson C, Narita M. How Soon can Smear Positive Tuberculosis Patients be Released from Inpatient Isolation? Infection Control and Hospital Epidemiology. 2010; 31(1): 78-84.
12. Parimon T, Spitters CE, Muangman N, Euathrongchit J, Oren E, Narita M. Unexpected Pulmonary Involvement in Extrapulmonary Tuberculosis Patients. Chest. 2008; 134(3): 589-594.
13. Ashworth M,  Horan KL, Freeman R, Oren E, Narita M, Cangelosi GA. Use of PCR-based Mycobacterium tuberculosis Genotyping to Prioritize Tuberculosis Outbreak Control Activities. Journal of Clinical Microbiology. 2008; 46(3):856-862.
14. Oeltmann JE, Oren E, Haddad MB, Lake LK, Harrington T, Ijaz K, Narita M. Tuberculosis Outbreak in Marijuana Users, Seattle, Washington, 2004. Emerging Infectious Diseases. 2006; 12(7):1156-1159.
15. Oren E, Smith NL, Doggen CJ, Heckbert SR, Lematire RN. Body mass index and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2006 Oct;4(10):2273-5
16. Freeman R, Kato-Maeda M, Hauge KA, Oren E, Narita M, Wallis CK, Nolan C, Small PM, Cangelosi GA. Use of Rapid Genomic Deletion Typing to Monitor a Tuberculosis Outbreak within an Urban Homeless Population. Journal of Clinical Microbiology. 2005; 43(11):5550-5554.
17. Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket Expenditures for Oral Contraceptives and Number of Pill Packs Obtained per Purchase. Journal of the American Women’s Medical Association. 2004;59(1):36-42.
18. Oren E, Shaffer ER and Guglielmo BJ. Impact of Emerging Technologies Upon Medication Errors and Adverse Drug Events: A Review of the Evidence. American Journal of Health-System Pharmacists 2003; 60:1447-1458.
19. Oren E, Griffiths LP and Guglielmo BJ. Demographics of Antimicrobial Overrides Associated with Automated Dispensing Machines. American Journal of Health-System Pharmacists 2002; 59 (15): 1445-1448.
20. Oren E, McCart G, Phillips KA. Evaluating the Potential Impact of Pharmacogenomics on ADRs: A Subject Review. Journal of Managed Care Pharmacy 2002; 8 (4): 285-290.
21. Phillips KA, Veenstra DL, Oren E, Lee JK and Sadee WS. The Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions: A Systematic Review. JAMA 2001; 286 (18): 2270-2279.

Involvement in my research
• If you are a student interested in my research, or other training opportunities, please email me
• If you are interested in Epidemiology at MEZCOPH, go here

Research Synopsis

Research interests: - Infectious Disease Epidemiology - TB - Spatial epidemiology - Social Epidemiology

The University of Arizona